Literature DB >> 11906966

Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors.

Valeria Spelta1, Lin-Hua Jiang, Annmarie Surprenant, R Alan North.   

Abstract

1. Currents through heteromeric P2X(2/3) receptors were evoked by applying alpha,beta-methylene-ATP to human embryonic kidney cells transfected with cDNAs encoding the P2X(2) and P2X(3) subunits. The concentration of alpha,beta-methylene-ATP were < or =30 microM because higher concentrations can activate homomeric P2X(2) receptors. The kinetics of action of three structurally unrelated antagonists were studied; these were 2', 3'-O-(2,4,6,trinitrophenyl)-ATP (TNP-ATP), pyridoxal-5-phosphate-6-azophenyl-2',4'-disulphonate (PPADS) and suramin. The association and dissociation rate constants were determined by pre-applying the antagonist for various periods prior to the co-application of agonist and antagonist, or by changing the solution from one containing only the agonist to one containing both agonist and antagonist. The high affinity of TNP-ATP for the P2X(2/3) receptor (K(D) approximately 2 nM) results from fast binding (k(+1) approximately 100 microM(-1) s(-1)) rather than slow unbinding (k(-1) approximately 0.3 s(-1)). For suramin (K(D) approximately 1 microM) the association rate constant ( approximately 1 microM(-1) s(-1)) was 100 times slower than that of TNP-ATP but the dissociation rate constant was similar (k(-1) approximately 1 s(-1)). PPADS (K(D) approximately 0.1 microM) associated and dissociated some 100 - 10,000 times more slowly than the other antagonists.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906966      PMCID: PMC1573256          DOI: 10.1038/sj.bjp.0704591

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

Review 1.  ATP, P2X receptors and pain pathways.

Authors:  Y Ding; P Cesare; L Drew; D Nikitaki; J N Wood
Journal:  J Auton Nerv Syst       Date:  2000-07-03

Review 2.  P2X receptors in sensory neurones.

Authors:  G Burnstock
Journal:  Br J Anaesth       Date:  2000-04       Impact factor: 9.166

3.  Novel mechanism of inhibition by the P2 receptor antagonist PPADS of ATP-activated current in dorsal root ganglion neurons.

Authors:  C Li
Journal:  J Neurophysiol       Date:  2000-05       Impact factor: 2.714

4.  Contribution of individual subunits to the multimeric P2X(2) receptor: estimates based on methanethiosulfonate block at T336C.

Authors:  R Stoop; S Thomas; F Rassendren; E Kawashima; G Buell; A Surprenant; R A North
Journal:  Mol Pharmacol       Date:  1999-11       Impact factor: 4.436

Review 5.  Pharmacology of cloned P2X receptors.

Authors:  R A North; A Surprenant
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

6.  Guinea-pig sympathetic neurons express varying proportions of two distinct P2X receptors.

Authors:  Y Zhong; P M Dunn; G Burnstock
Journal:  J Physiol       Date:  2000-03-01       Impact factor: 5.182

Review 7.  ATP as a peripheral mediator of pain.

Authors:  S G Hamilton; S B McMahon
Journal:  J Auton Nerv Syst       Date:  2000-07-03

Review 8.  P2X receptors mediate ATP-induced primary nociceptive neurone activation.

Authors:  P A Bland-Ward; P P Humphrey
Journal:  J Auton Nerv Syst       Date:  2000-07-03

9.  Functional properties of heteromeric P2X(1/5) receptors expressed in HEK cells and excitatory junction potentials in guinea-pig submucosal arterioles.

Authors:  A Surprenant; D A Schneider; H L Wilson; J J Galligan; R A North
Journal:  J Auton Nerv Syst       Date:  2000-07-03

10.  Characterization of cultured dorsal root ganglion neuron P2X receptors.

Authors:  B D Grubb; R J Evans
Journal:  Eur J Neurosci       Date:  1999-01       Impact factor: 3.386

View more
  19 in total

1.  Antagonism of P2X3-containing channels: commentary on Spelta et al.

Authors:  Michael F Jarvis; Edward C Burgard
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  2', 3'-O-(2,4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor.

Authors:  Torben R Neelands; Edward C Burgard; Marie E Uchic; Heath A McDonald; Wende Niforatos; Connie R Faltynek; Kevin J Lynch; Michael F Jarvis
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

Review 3.  Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Michihiro Ohno; Bhalchandra V Joshi; Pedro Besada; Bin Xu; Susanna Tchilibon
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

4.  Identification of P2X₃ and P2X₇ purinergic receptors activated by ATP in rat lacrimal gland.

Authors:  Robin R Hodges; Joanna Vrouvlianis; Rachel Scott; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

Review 5.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

Review 6.  Activation and regulation of purinergic P2X receptor channels.

Authors:  Claudio Coddou; Zonghe Yan; Tomas Obsil; J Pablo Huidobro-Toro; Stanko S Stojilkovic
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

7.  Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation.

Authors:  David Richards; Joel R Gever; Anthony P Ford; Samuel J Fountain
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

Review 8.  P2X3 receptors and peripheral pain mechanisms.

Authors:  R Alan North
Journal:  J Physiol       Date:  2003-06-27       Impact factor: 5.182

9.  Dehydroepiandrosterone potentiates native ionotropic ATP receptors containing the P2X2 subunit in rat sensory neurones.

Authors:  Mathias De Roo; Jean-Luc Rodeau; Rémy Schlichter
Journal:  J Physiol       Date:  2003-07-04       Impact factor: 5.182

Review 10.  Purinergic mechanosensory transduction and visceral pain.

Authors:  Geoffrey Burnstock
Journal:  Mol Pain       Date:  2009-11-30       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.